BIO aims to increase access to medicines in developing world.
Share:
Press Release Summary:
According to BIO President and CEO, BIO's Policy Statement on Options for Increasing Access to Medicines in the Developing World is the first time industry has come together to identify viable options that individual companies should consider as they develop and market their products worldwide. BIO encourages all members and other biopharmaceutical companies to review options outlined in Policy Statement and consider how they as individual companies can contribute to this effort.
Original Press Release:
BIO Announces New Policy on Options for Increasing Access to Medicines in the Developing World
WASHINGTON, D.C. - Biotechnology Industry Organization (BIO) President and CEO released the following statement on a set of options to increase access to medicines in the developing world which was announced at the Partnering for Global Health Forum 2010 today:
"While many of BIO's members are taking individual steps to address the global health crisis, we recognize as an industry that more can and should be done. We believe that the goals of increasing access to medicines, respecting intellectual property rights, and maintaining commercial viability are mutually supportive.
"BIO's Policy Statement on Options for Increasing Access to Medicines in the Developing World is the first time that we as an industry have come together to identify viable options that we believe individual companies should consider as they develop and market their products worldwide.
"We strongly encourage all BIO members and other biopharmaceutical companies to review the options outlined in this Policy Statement and consider how they as individual companies can contribute to this effort.
"Working together, we can meet the global health challenge and help save and improve the quality of life for millions of patients around the world."
The Policy Statement is available at http://www.bio.org/healthcare/innovation/Access_to_Medicines_Policy_Statement_Final.pdf
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
